Dr. Litvack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8840 Wilshire Blvd
2nd floor
Beverly Hills, CA 90211Phone+1 213-380-7130Fax+1 310-967-1744
Education & Training
- Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1982 - 1985
- McGill University Faculty Medicine HospitalInternal Medicine, 1979 - 1982
- McGill University Faculty of MedicineClass of 1979
Certifications & Licensure
- OR State Medical License 1988 - Present
- CA State Medical License 1982 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 74 citationsInfluence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry.Thomas Robertson, Elizabeth D. Kennard, Sameer Mehta, Jeffrey J. Popma, Joseph P. Carrozza
The American Journal of Cardiology. 1997-11-20 - 100 citationsEffects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosisRaj Makkar, Neal L. Eigler, Sanjay Kaul, Aaron Frimerman, Mamoo Nakamura
European Heart Journal. 1998-10-01 - 31 citationsPulsed laser angioplasty: wavelength power and energy dependencies relevant to clinical application.Frank Litvack, Warren S. Grundfest, Tsvi Goldenberg, James B. Laudenslager, Thomas J. Pacala
Lasers in Surgery and Medicine. 1988-01-01
Press Mentions
- V-wave Raises $98m to Support Further Development of Cardiac ShuntSeptember 23rd, 2020
- Billionaire Efrem Kamen Pulled Cash from Otonomy Inc (OTIC) and Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Welcoming Gilead Sciences, Inc. (GILD)September 5th, 2017
- V-wave Scores $28 Mln Series BJanuary 11th, 2016
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: